(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 5.52% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Staar Surgical Co's revenue in 2026 is $339,590,000.On average, 14 Wall Street analysts forecast STAA's revenue for 2026 to be $17,193,870,674, with the lowest STAA revenue forecast at $15,793,850,640, and the highest STAA revenue forecast at $18,833,578,951. On average, 14 Wall Street analysts forecast STAA's revenue for 2027 to be $18,594,893,587, with the lowest STAA revenue forecast at $17,164,285,723, and the highest STAA revenue forecast at $20,255,160,897.
In 2028, STAA is forecast to generate $20,007,951,056 in revenue, with the lowest revenue forecast at $18,119,528,618 and the highest revenue forecast at $22,576,827,356.